CEFPROZIL

Generic: CEFPROZIL

Lupin PharmaceuticalsManufacturer
ORALRoute
CEFPROZILActive Substance
2005-12-08Original Approval

CEFPROZIL is FDA application ANDA065276, sponsored by LUPIN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2021-03-26
Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (wh

Superpotent Drug

Top Reported Reactions

1
CHRONIC KIDNEY DISEASE
89 reports
2
DRUG HYPERSENSITIVITY
73 reports
3
COUGH
64 reports
4
ACUTE KIDNEY INJURY
59 reports
5
DYSPNOEA
59 reports
6
RASH
57 reports
7
PNEUMONIA
56 reports
8
PYREXIA
55 reports
9
FATIGUE
52 reports
10
RENAL FAILURE
52 reports